Last month saw the Spanish Ministry of Health and Consumer Affairs, inliaison with the European Medicines Evaluation Agency, host the first international encounter with the regulatory authorities of 17 Ibero-American countries: Argentina, Bolivia, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay and Venezuela.
The meeting concentrated principally on pharmaceutical regulations in the European Union, and Spain in particular. Delegates were able to discuss the new European procedures and to present recent regional developments in Latin America. It is envisaged that more regular contacts will be established with these countries in the future, said the EMEA.
The Spanish meeting was followed by a visit of the IberoAmerican delegates to the EMEA in London, UK.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze